Investing Profile

Robert Garland

VCInvestor

Venture Partner at New Enterprise Associates (NEA)

nea.comSan Francisco, California

Your Intro Paths to Robert Garland

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Robert Garland on

Current Investing Position

Investment Range

$2.0M - $50.0M

Sweet Spot

$25.0M

Investments On Record

Current Fund Size

$6.2B

Robert Garland is on these Sector & Stage Rankings

Robert Garland's Investments On Record (4)

Company	StageDateRound Size	Total Raised
Cleave Therapeutics	Series BAug 2016$37M Series AApr 2013$10M	$100M
Co-investors: Carol Gallagher (New Enterprise Associates (NEA)), Andrew Schwab (5am Ventures), Peter Thompson (OrbiMed), Kush Parmar (5am Ventures), Marc Singer (Osage University Partners), Larry Lasky (The Column Group), Alfred Scheidegger (Nextech Invest)
Sagimet Biosciences	Series DDec 2014$29M Series CJun 2013$20M Series UnknownOct 2012$8M Series UnknownJan 2012$20M Series BJul 2009$30M	$190M
Co-investors: Matthew McAviney (New Enterprise Associates (NEA)), Beth Seidenberg (Westlake Village BioPartners), David Mott (Mott Family Capital)
Trevena	Series BJul 2010$35M Series AMar 2008$24M	$59M
Co-investors: Terry McGuire (Polaris Partners), Farah Champsi (InterWest)
Cardioxyl Pharmaceuticals	Series ADec 2006$15M	$58M
Co-investors: Peter Thompson (OrbiMed), Bill Harrington (Osage University Partners), James Barrett